Age at diagnosis, skin color, tumor size, lymph node involvement, clinical stage at diagnosis, estrogen receptor, progesterone receptor, HER2, the type of health service, private health insurance coverage, time elapsed between diagnosis and surgery, and the type of treatment. This evidence concerns the gene ERBB2 and neoplasm.